# Christian Angermayer > Christian Angermayer is a person that is a German entrepreneur, investor and film producer who founded Apeiron Investment Group and has invested across biotechnology, psychedelics, longevity, fintech and cryptocurrency. - Canonical URL: https://iq.wiki/wiki/christian-angermayer - Categories: People in crypto - Tags: Artist, Bitcoin, Advisor, Founder, Investor - Created: 2026-09-08T22:41:31.233Z - Last updated: 2026-09-08T22:41:31.233Z - Source: IQ.wiki — the world's largest blockchain and crypto encyclopedia (https://iq.wiki) --- **Christian Angermayer** is a German entrepreneur, investor, executive film producer and political advisor known as the founder of Apeiron Investment Group and the biotechnology company atai Life Sciences, and as a co-founder of the Enhanced Games. He built his early fortune in biotechnology before assembling a wide portfolio spanning life sciences, psychedelics-based medicine, longevity research, financial technology, cryptocurrency and emerging technologies. [\[1\]](#cite-id-c9dh772j0b) [\[4\]](#cite-id-fFmGDBysdXFGeIYE) ## Early Life and Education Christian Angermayer was born on 26 April 1978 in Wiesau, Germany. In 1998, he began studying biochemistry at the University of Bayreuth, where he met professors Roland Kreutzer and Stefan Limmer, who were researching RNA interference as a gene-targeting technique. In 2000, Angermayer and the two professors co-founded Ribopharma AG. Although he held only a minority stake in the company, Ribopharma secured government funding, enabling Angermayer to leave university and focus on the venture. [\[1\]](#cite-id-c9dh772j0b) [\[4\]](#cite-id-fFmGDBysdXFGeIYE) ## Business Career His investment activities run through Apeiron, a private investment firm, family office and merchant-banking business based in Sliema, Malta. Angermayer has been a prominent proponent of what commentators call the "psychedelic renaissance" in medicine, and Sifted described him as "instrumental in the founding of Compass Pathways and chairman of atai Life Sciences" and "leading a global psychedelic renaissance." [\[3\]](#cite-id-hiav6t2r0i) [\[4\]](#cite-id-fFmGDBysdXFGeIYE) ### Ribopharma and Early Ventures In 2000, Angermayer and professors Roland Kreutzer and Stefan Limmer founded Ribopharma AG, which received backing from the German government, prompting Angermayer to leave his studies. In 2003 Ribopharma merged with the Massachusetts-based Alnylam Pharmaceuticals, which later went public; Angermayer sold his stake in the merger, a deal that made him a multimillionaire at the age of 25.[\[2\]](#cite-id-diuv69ws3x)​ ### Apeiron Investment Group Apeiron Investment Group is the private investment firm, family office and merchant-banking business that Angermayer founded and owns. It invests across life sciences, financial technology, cryptocurrency and future technologies, and Forbes states that the Malta-based firm holds shares in several publicly traded firms and private companies in the United States, Germany, Canada and Australia.[\[2\]](#cite-id-diuv69ws3x) The firm's headquarters are in Sliema, Malta, with a workforce distributed across several countries.[\[1\]](#cite-id-c9dh772j0b)​ Apeiron's international venture arm is Presight Capital, which Angermayer co-founded with Fabian Hansen and which raised its first fund totalling $80 million in 2019. In 2020, Peter Thiel became a strategic partner and anchor investor of Elevat3, a fund set up by Apeiron to invest in startups in German-speaking countries. [\[6\]](#cite-id-6E6fweTa8XPOu5Xe) ### Biotechnology and Psychedelics Angermayer founded the biotechnology company atai Life Sciences in 2018, focused on developing treatments for mental-health conditions including depression, anxiety and addiction, including research on psychedelic compounds such as psilocybin and DMT. Peter Thiel is a backer of the company. Sifted has described him as chairman of atai and as instrumental in the founding of Compass Pathways, and Compact called him a futurist and "the most enthusiastic and visible psychedelic salesman." Bloomberg has referred to him as "_he, of magic mushrooms fame_," while Scientific American in 2019 described him as "_one of the driving forces behind the movement to turn long-shunned psychoactive substances … into approved medications for depression and other mental_ illnesses." [\[7\]](#cite-id-f6nxw15OUiUnPXnI) [\[8\]](#cite-id-NABtmV9Cmv17GRiI) ### Cryptocurrency and Financial Technology Forbes remarked in 2024 that Angermayer is a pioneer in the cryptocurrency industry and was "seemingly behind every flashy investment of the last decade." He is a co-founder of the [blockchain](https://iq.wiki/wiki/blockchain) startup [Plasma (XPL)](https://iq.wiki/wiki/plasma-xpl), a [stablecoin](https://iq.wiki/wiki/stablecoin)-focused [blockchain](https://iq.wiki/wiki/blockchain) designed as a sidechain of [Bitcoin](https://iq.wiki/wiki/bitcoin), and invested in its seed round alongside Peter Thiel. He co-founded or invested in [Bullish](https://iq.wiki/wiki/bullish) alongside investors including Peter Thiel, Mike Novogratz, Richard Li and Nomura. Angermayer and Mike Novogratz co-founded Cryptology Asset Group and have jointly invested in psychedelic ventures; Forbes also lists among his holdings the [blockchain](https://iq.wiki/wiki/blockchain) holding company Samara, alongside Novogratz as co-investor.[\[2\]](#cite-id-diuv69ws3x) [\[9\]](#cite-id-qMii3zaKOT0ZFUT5) ### Enhanced Games Angermayer is a co-founder of the Enhanced Games, a planned alternative to the Olympics that permits performance-enhancing substances. [Donald Trump Jr.](https://iq.wiki/wiki/donald-trump-jr) and Peter Thiel, both described as his friends, are investors in the venture. The Guardian, in a May 2026 profile by Sean Ingle datelined Las Vegas, described him as the German billionaire behind the project and framed the inaugural event as a "Steroid Olympics" promoting performance-enhancing drugs to the masses; the piece drew its headline from his own words, "_We're the good ones. I really believe that_."[\[3\]](#cite-id-hiav6t2r0i)​ Angermayer has publicly promoted the venture's expansion and reported results. In posts summarizing the company's second-quarter 2026 figures, he stated that the inaugural Games had secured roughly $32 million of sponsorship contract value and produced revenue of $17.7 million, against an adjusted EBITDA loss of $42.7 million attributed largely to one-off costs of staging the event, an IRB clinical trial, and a de-SPAC merger.[\[1\]](#cite-id-c9dh772j0b) He has said the company launched a telehealth platform called "Live Enhanced" offering prescription therapies and supplements, secured a two-year media-rights agreement with Roku, and staged an "Enhanced Breakers" strongman series whose July 2026 debut in Los Angeles featured Hafthor Bjornsson attempting to break his own deadlift world record.[\[1\]](#cite-id-c9dh772j0b) [\[5\]](#cite-id-HLOJ6WFmouvYXVOo) ## Political and Diplomatic Ties Angermayer has been described as a notable but controversial social networker with international ties to political figures, business people and media personalities. He is a member of the World Economic Forum's Young Global Leaders programme and of its Global Growth Companies' Advisory Council since 2011, is a member of the Clinton Global Initiative, and has hosted exclusive side events as one of the sponsors of the Munich Security Conference. He sits on the Presidential Advisory Council of Rwandan president Paul Kagame and is described as a longtime advisor to Kagame; in 2019 he headed a business faction of more than 45 European investors within a delegation Tony Blair led to Kigali after Blair's Africa Governance Initiative was established in Rwanda. [\[1\]](#cite-id-c9dh772j0b) [\[3\]](#cite-id-hiav6t2r0i) [\[4\]](#cite-id-fFmGDBysdXFGeIYE)